TipRanks
pc:trxxx

Tr1X

4242 Campus Point Ct Suite 500 San Diego, California 92121, US
https://www.tr1x.bio/
Tr1X is a clinical-stage biotechnology company focused on developing innovative cell therapies to address autoimmune and inflammatory diseases. The company specializes in creating off-the-shelf, allogeneic Tr1 and CAR-Tr1 Treg cell therapies, which aim to reset the immune system, offering enhanced safety, scalability, and accessibility. Tr1X's therapies are designed to restore immune tolerance without the need for traditional lymphodepletion, providing a promising approach to treating conditions such as progressive multiple sclerosis and refractory Crohn’s disease.

Leadership & Board

Current Number of Employees44
Current LinkedIn Followers5,119

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Employee Trend

Tr1X had 44 employees as of September 14, 2026. The number of employees decreased by 1 (2.22%) week-over-week.
44Latest Employee Count
1(-2.22%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Tr1X had 5,119 followers as of September 14, 2026. The number of followers increased by 18 (0.35%) week-over-week.
5,119Latest Followers Count
18(0.35%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 14, 2025
Investment
$50.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Tr1X, helping you discover and navigate related company profiles.

Related News and Analysis